Australia is closely awaiting the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://finnianrtkq925842.wikiusnews.com/2560395/this_new_drug_retatrutide_australia_a_potential_breakthrough_for_weight_management